Evidence map›Paper›PMID 25001599›Full record

ArticleNature communications2014

Cdon acts as a Hedgehog decoy receptor during proximal-distal patterning of the optic vesicle.

Marcos Julián Cardozo, Luisa Sánchez-Arrones, Africa Sandonis, Cristina Sánchez-Camacho, Gaia Gestri, Stephen W Wilson, Isabel Guerrero, Paola Bovolenta

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Creb5 controls its own expression and directly induces the joint interzone regulatory program.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Marcos Julián Cardozo1] Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, 28049 Madrid Spain [2] Ciber de Enfermedades Raras (CIBERER), ISCIII, c/ Nicolas Cabrera 1, 28049 Madrid Spain.
Luisa Sánchez-Arrones1] Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, 28049 Madrid Spain [2] Ciber de Enfermedades Raras (CIBERER), ISCIII, c/ Nicolas Cabrera 1, 28049 Madrid Spain.
Africa Sandonis1] Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, 28049 Madrid Spain [2] Ciber de Enfermedades Raras (CIBERER), ISCIII, c/ Nicolas Cabrera 1, 28049 Madrid Spain.
Cristina Sánchez-Camacho1] Ciber de Enfermedades Raras (CIBERER), ISCIII, c/ Nicolas Cabrera 1, 28049 Madrid Spain [2].
Gaia GestriDepartment of Cell and Developmental Biology, University College London, Gower Street, London WC1E 6BT, UK.
Stephen W WilsonDepartment of Cell and Developmental Biology, University College London, Gower Street, London WC1E 6BT, UK.
Isabel GuerreroCentro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, 28049 Madrid Spain.
Paola Bovolenta1] Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, 28049 Madrid Spain [2] Ciber de Enfermedades Raras (CIBERER), ISCIII, c/ Nicolas Cabrera 1, 28049 Madrid Spain.
Consejo Superior de Investigaciones Científicas · ESUniversity College London · GBCentre for Biomedical Network Research on Rare Diseases · ESCentro de Biología Molecular Severo Ochoa · ESInstituto de Investigación de Enfermedades Raras · ESUniversidad Autónoma de Madrid · ES

Funding

Medical Research Council G0501487Medical Research Council G0900994Medical Research Council MR/L003775/1Wellcome TrustWellcome Trust 089227/Z09/Z
6 · The paper itself

Abstract

Patterning of the vertebrate optic vesicle into proximal/optic stalk and distal/neural retina involves midline-derived Hedgehog (Hh) signalling, which promotes stalk specification. In the absence of Hh signalling, the stalks are not specified, causing cyclopia. Recent studies showed that the cell adhesion molecule Cdon forms a heteromeric complex with the Hh receptor Patched 1 (Ptc1). This receptor complex binds Hh and enhances signalling activation, indicating that Cdon positively regulates the pathway. Here we show that in the developing zebrafish and chick optic vesicle, in which cdon and ptc1 are expressed with a complementary pattern, Cdon acts as a negative Hh signalling regulator. Cdon predominantly localizes to the basolateral side of neuroepithelial cells, promotes the enlargement of the neuroepithelial basal end-foot and traps Hh protein, thereby limiting its dispersion. This Ptc-independent function protects the retinal primordium from Hh activity, defines the stalk/retina boundary and thus the correct proximo-distal patterning of the eye.

Indexed as

AnimalsAnimals, Genetically ModifiedBinding SitesBody PatterningCell Adhesion MoleculesChick EmbryoEyeHedgehog ProteinsHEK293 CellsHumansMembrane ProteinsNeural Cell Adhesion MoleculesPatched-1 ReceptorPatched ReceptorsReceptors, Cell SurfaceZebrafishBOC protein, zebrafishCdon protein, zebrafishCell Adhesion MoleculesHedgehog ProteinsMembrane ProteinsNeural Cell Adhesion MoleculesPatched-1 ReceptorPatched ReceptorsPTCH1 protein, humanptch1 protein, zebrafishReceptors, Cell SurfaceZebrafish Proteins

Identifiers

PMID25001599
PMCPMC4102123
OpenAlexW2098491699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.